SYSTEMATIC LITERATURE REVIEWS AT THE HEART OF HEALTH TECHNOLOGY ASSESSMENT- A COMPARISON ACROSS MARKETS

Author(s)

Rycroft CE*1;Fernandez M2, Copley-Merriman C3 1RTI Health Solutions, Manchester, United Kingdom, 2RTI Health Solutions, RTP, NC, USA, 3RTI Health Solutions, Ann Arbor, MI, USA

OBJECTIVES: Requirements for systematic literature reviews (SLRs) within a Health Technology Assessment (HTA) submission vary across the world. The objective of this study is to compare clinical and economic SLR requirements issued by eight HTA agencies in the United Kingdom (England and Wales, Wales, Scotland), Ireland, Germany, Sweden, Canada, and Australia.  METHODS: SLR requirements issued by the National Institute for Health and Care Excellence (NICE), All Wales Medicines Strategy Group (AWMSG), Scottish Medicines Consortium (SMC), National Centre for Pharmacoeconomics (NCPE), Gemeinsamer Bundesausschuss (G-BA) (Federal Joint Committee), The Dental and Pharmaceutical Benefits Agency (TLV), Canadian Agency for Drugs and Technologies in Health (CADTH), and Pharmaceutical Benefits Advisory Committee (PBAC) were compared, and a checklist of requirements was compiled. RESULTS: SLRs of the clinical and economic evidence underpin the HTA process. However, HTA agencies vary on the specific requirements for each and the need for critical appraisal of identified clinical studies and economic analyses. NICE requirements are the most prescriptive, whereas AWMSG and TLV have few stated SLR requirements. All agencies require a clinical SLR, although AWMSG does not specify outright but requires a clinical SLR to determine economic model inputs. Four agencies require both a clinical SLR and critical appraisal of the included studies (NICE, NCPE, G-BA, and PBAC), although recommended appraisal tools vary. NICE and CADTH require both an SLR and a critical appraisal of existing economic evaluations for the intervention of interest; PBAC requires an SLR of only economic evaluations. NICE, SMC, AWMSG, and NCPE require an SLR of utility data, and only NICE and SMC specify the need for an SLR of cost and resource use data. A more detailed analysis of specific methodology requirements will be presented. CONCLUSIONS: Although SLR requirements vary between HTA agencies, a clinical SLR is a key requirement for all eight agencies investigated.

Conference/Value in Health Info

2013-11, ISPOR Europe 2013, The Convention Centre Dublin

Value in Health, Vol. 16, No. 7 (November 2013)

Code

PHP169

Topic

Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×